Preferred Label : daptomycin;
MeSH definition : A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.;
MeSH synonym : deptomycin;
CISMeF synonym : cubist brand of injectable daptomycin;
MeSH hyponym : daptomycin, 9-L beta-Aspartic acid; LY-146032; cubicin; Daptomycin, 9 L beta Aspartic Acid; LY 146032; LY146032;
MeSH CAS label : N-decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine-epsilon1-lactone;
MeSH Related Number : daptomycin, 9-L beta-Aspartic acid; 103060-53-3 (Daptomycin); 123180-72-3;
Registry Number MeSH : 103060-53-3;
Related CAS MeSH : 123180-72-3 (Daptomycin, 9-L beta-Aspartic acid);
Wikipedia link : https://en.wikipedia.org/wiki/Cubicin;
Is substance : O;
UNII : NWQ5N31VKK;
InChIKey : DOAKLVKFURWEDJ-QCMAZARJSA-N;
Origin ID : D017576;
UMLS CUI : C0057144;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
https://www.has-sante.fr/jcms/p_3185837/fr/cubicin
2020
false
false
false
France
daptomycin
child
Staphylococcus aureus bacteraemia
bacteremia
staphylococcal infections
staphylococcus aureus
anti-bacterial agents
evaluation of the transparency committee
daptomycin
---
https://www.has-sante.fr/jcms/p_3067145/fr/daptomycine-medac
2019
false
false
false
France
French
evaluation of the transparency committee
daptomycin
drugs, generic
---
https://www.has-sante.fr/portail/jcms/c_2821334/fr/daptomycine-reddy
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Product containing daptomycin (medicinal product)
daptomycin
daptomycin
---
https://www.has-sante.fr/portail/jcms/c_2788612/fr/daptomycine-hospira
2017
false
false
false
France
French
evaluation of the transparency committee
daptomycin
---
https://pharmacomedicale.org/medicaments/par-specialites/item/daptomycine
2017
false
false
false
France
anti-bacterial agents
drug information
daptomycin
---
https://www.has-sante.fr/portail/jcms/c_2806283/fr/daptomycine-accord
2017
false
false
false
France
French
evaluation of the transparency committee
daptomycin
---
https://www.ema.europa.eu/medicines/human/EPAR/Daptomycin-Hospira
2017
false
United Kingdom
French
English
soft tissue infections
Bacteremia caused by Staphylococcus aureus (finding)
Right-sided Staphylococcus aureus endocarditis (disorder)
syndication feed
complicated skin and soft tissue infection
antibiotic therapy
drugs, generic
adult
anti-bacterial agents
daptomycin
treatment outcome
endocarditis, bacterial
staphylococcal infections
staphylococcus aureus
bacteremia
drug compounding
daptomycin
anti-bacterial agents
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
skin diseases, infectious
drug incompatibility
drug approval
daptomycin
package leaflet
summary of product characteristics
drug evaluation
---
http://www.has-sante.fr/portail/jcms/c_2722808/fr/cubicin
2016
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
child
skin diseases, bacterial
soft tissue infections
complicated skin and soft tissue infection
anti-bacterial agents
daptomycin
injections, intravenous
infusions, intravenous
daptomycin
adolescent
---
https://www.ema.europa.eu/medicines/human/EPAR/Cubicin
2012
false
United Kingdom
French
English
soft tissue infections
Bacteremia caused by Staphylococcus aureus (finding)
Right-sided Staphylococcus aureus endocarditis (disorder)
syndication feed
complicated skin and soft tissue infection
antibiotic therapy
Contraindications, Procedure
adult
anti-bacterial agents
daptomycin
daptomycin
daptomycin
anti-bacterial agents
anti-bacterial agents
treatment outcome
drug evaluation
infusions, intravenous
endocarditis, bacterial
staphylococcal infections
staphylococcus aureus
bacteremia
drug compounding
daptomycin
anti-bacterial agents
daptomycin
anti-bacterial agents
powders
renal insufficiency
aged
drug interactions
pregnancy
breast feeding
daptomycin
anti-bacterial agents
daptomycin
anti-bacterial agents
drug evaluation, preclinical
anti-bacterial agents
skin diseases, infectious
daptomycin
drug incompatibility
drug storage
drug approval
drug labeling
daptomycin
package leaflet
summary of product characteristics
drug evaluation
Contraindications, Drug
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00039
2011
false
false
false
Canada
drug information
daptomycin
powders
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Cubicin_Oct-22-08_f.pdf
2008
Canada
French
daptomycin
anti-bacterial agents
skin diseases, bacterial
staphylococcal infections
daptomycin
drug evaluation
---
http://www.has-sante.fr/portail/display.jsp?id=c_458661
2006
France
evaluation of the transparency committee
powders
daptomycin
---